Zoetis Inc. (NYSE:ZTS) Shares Sold by Gouws Capital LLC

Key Points

• Gouws Capital LLC reduced its stake in Zoetis Inc. by 10.3%, holding 16,494 shares valued at approximately $2.72 million as of its latest SEC filing.
• Zoetis recently reported $1.76 earnings per share, surpassing analysts' estimates and indicating a 4.2% year-over-year revenue growth to $2.46 billion.
• The company declared a quarterly dividend of $0.50 per share, translating to an annual yield of 1.4%, with a payout ratio of 34.42%.

Gouws Capital LLC reduced its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 10.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,494 shares of the company's stock after selling 1,897 shares during the quarter. Zoetis comprises approximately 1.6% of Gouws Capital LLC's portfolio, making the stock its 19th largest holding. Gouws Capital LLC's holdings in Zoetis were worth $2,716,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Navigoe LLC purchased a new position in Zoetis during the 4th quarter worth $30,000. Cornerstone Planning Group LLC grew its position in Zoetis by 79.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock worth $30,000 after purchasing an additional 88 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its position in Zoetis by 87.6% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 257 shares of the company's stock worth $42,000 after purchasing an additional 120 shares during the last quarter. Sound Income Strategies LLC grew its position in Zoetis by 141.4% during the 1st quarter. Sound Income Strategies LLC now owns 280 shares of the company's stock worth $46,000 after purchasing an additional 164 shares during the last quarter. Finally, Bfsg LLC grew its position in Zoetis by 614.6% during the 1st quarter. Bfsg LLC now owns 293 shares of the company's stock worth $48,000 after purchasing an additional 252 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Zoetis Price Performance

Shares of NYSE ZTS traded up $0.70 during midday trading on Tuesday, hitting $149.72. The company had a trading volume of 2,578,354 shares, compared to its average volume of 3,848,447. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a twelve month low of $139.70 and a twelve month high of $200.33. The business has a 50-day simple moving average of $155.89 and a two-hundred day simple moving average of $159.50. The firm has a market capitalization of $66.35 billion, a price-to-earnings ratio of 25.77, a price-to-earnings-growth ratio of 2.43 and a beta of 0.88.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The firm had revenue of $2.46 billion during the quarter, compared to analysts' expectations of $2.41 billion. During the same quarter last year, the business earned $1.56 earnings per share. The business's revenue for the quarter was up 4.2% compared to the same quarter last year. Equities research analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.3%. Zoetis's payout ratio is presently 34.42%.

Analysts Set New Price Targets

ZTS has been the topic of several research reports. Stifel Nicolaus downgraded shares of Zoetis from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $165.00 to $160.00 in a research report on Wednesday, June 18th. UBS Group lowered their price objective on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 7th. Leerink Partnrs downgraded shares of Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th. Leerink Partners downgraded shares of Zoetis from an "outperform" rating to a "market perform" rating and lowered their target price for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $215.00 target price (up previously from $210.00) on shares of Zoetis in a report on Monday. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $205.25.

Insider Transactions at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 652 shares of Zoetis stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total transaction of $110,840.00. Following the completion of the transaction, the executive vice president owned 15,129 shares in the company, valued at approximately $2,571,930. The trade was a 4.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.16% of the company's stock.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.